Rua Bioscience Limited (NZE:RUA)
New Zealand flag New Zealand · Delayed Price · Currency is NZD
0.0420
+0.0010 (2.44%)
Oct 3, 2025, 4:29 PM NZST

Rua Bioscience Income Statement

Millions NZD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212019 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2019 - 2020
Operating Revenue
1.510.090.360.02-
Upgrade
Other Revenue
0.320.230.310.620.36
Upgrade
1.830.320.670.650.36
Upgrade
Revenue Growth (YoY)
477.39%-52.68%3.63%79.53%-
Upgrade
Cost of Revenue
0.980.20.340.13-
Upgrade
Gross Profit
0.850.110.330.520.36
Upgrade
Research & Development
0.941.181.592.981.9
Upgrade
Other Operating Expenses
3.243.555.185.124.74
Upgrade
Operating Expenses
4.184.736.778.16.64
Upgrade
Operating Income
-3.33-4.62-6.44-7.58-6.28
Upgrade
Interest Expense
-0.16-0.02-0.02-0.04-0.03
Upgrade
Interest & Investment Income
00.130.20.140.05
Upgrade
Currency Exchange Gain (Loss)
-0---
Upgrade
EBT Excluding Unusual Items
-3.49-4.51-6.25-7.49-6.27
Upgrade
Impairment of Goodwill
--8.25---
Upgrade
Gain (Loss) on Sale of Assets
0.03-0.53-0-
Upgrade
Asset Writedown
--0.43-5.57--
Upgrade
Other Unusual Items
0-5.86-0.09
Upgrade
Pretax Income
-3.46-13.72-5.96-7.49-6.17
Upgrade
Income Tax Expense
--01.15-1.76
Upgrade
Net Income
-3.46-13.72-5.96-8.64-4.42
Upgrade
Net Income to Common
-3.46-13.72-5.96-8.64-4.42
Upgrade
Shares Outstanding (Basic)
195158154144127
Upgrade
Shares Outstanding (Diluted)
195158154144127
Upgrade
Shares Change (YoY)
23.01%2.95%6.63%13.17%30.68%
Upgrade
EPS (Basic)
-0.02-0.09-0.04-0.06-0.03
Upgrade
EPS (Diluted)
-0.02-0.09-0.04-0.06-0.03
Upgrade
Free Cash Flow
-2.79-3.74-5.99-7.25-5.85
Upgrade
Free Cash Flow Per Share
-0.01-0.02-0.04-0.05-0.05
Upgrade
Gross Margin
46.54%35.47%49.21%80.06%100.00%
Upgrade
Operating Margin
-182.57%-1459.98%-962.92%-1175.69%-1748.19%
Upgrade
Profit Margin
-189.19%-4336.57%-891.46%-1338.73%-1229.48%
Upgrade
Free Cash Flow Margin
-152.79%-1181.50%-896.65%-1123.09%-1627.85%
Upgrade
EBITDA
-3-4.28-5.85-6.94-5.69
Upgrade
EBITDA Margin
-164.01%----
Upgrade
D&A For EBITDA
0.340.340.580.640.6
Upgrade
EBIT
-3.33-4.62-6.44-7.58-6.28
Upgrade
EBIT Margin
-182.57%----
Upgrade
Revenue as Reported
1.90.326.530.65-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.